NBBK Stock Analysis: NB Bancorp, Common Stock | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 927m USD | 12M Return: 13.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.96M
Qual. Beats: -1
Rev. Trend: 93.5%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 2.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NB Bancorp, Inc. (NBBK) is a bank holding company that operates Needham Bank, a community bank founded in 1892 and headquartered in Needham, Massachusetts. The company serves the Greater Boston metropolitan area and surrounding communities, offering a full suite of retail deposit products (checking, savings, money market, CDs, and IRAs) and a diversified lending portfolio that includes commercial real estate, multifamily residential, one- to four-family residential, mortgage warehouse, construction and land development, commercial and industrial, consumer, and home equity loans. The company also maintains an investment securities portfolio composed of U.S. treasury and federal agency securities, government-sponsored residential mortgage-backed securities, corporate bonds, SBA securities, and municipal bonds.
As a bank holding company structure, NB Bancorp owns and controls its banking subsidiary, a common regulatory framework in the U.S. that separates the holding entity from the operating bank. Its focus on the Greater Boston market-a dense, high-cost region with active commercial real estate-positions it within the regional and community banking sub-industry, where institutions typically compete through local relationship-based lending rather than nationwide scale.
- CRE loan concentration weighs on Greater Boston portfolio
- Net interest margin compresses as deposit costs rise
- Mortgage warehouse lending volume expands fee income
| Net Income: 52.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.17 > 1.0 |
| NWC/Revenue: 214.2% < 20% (prev -1.30k%; Δ 1.51k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 78.2m > Net Income 52.6m |
| Net Debt (-415.3m) to EBITDA (79.8m): -5.20 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.4m) vs 12m ago 6.88% < -2% |
| Gross Margin: 54.98% > 18% (prev 54.02%; Δ 0.96% > 0.5%) |
| Asset Turnover: 5.54% > 50% (prev 5.97%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: 0.51 > 6 (EBIT TTM 73.9m / Interest Expense TTM 145.8m) |
| A: 0.10 (Total Current Assets 6.84b - Total Current Liabilities 6.10b) / Total Assets 7.23b |
| B: 0.06 (Retained Earnings 457.0m / Total Assets 7.23b) |
| C: 0.01 (EBIT TTM 73.9m / Avg Total Assets 6.23b) |
| D: 0.13 (Book Value of Equity 842.8m / Total Liabilities 6.38b) |
| Altman-Z'' = 1.10 = BB |
| DSRI: 3.0 (Receivables 6.24b/19.5m, Revenue 345.6m/313.1m) |
| GMI: 0.98 (GM 54.02% / 54.98%) |
| AQI: 0.05 (AQ_t 0.05 / AQ_t-1 0.94) |
| SGI: 1.10 (Revenue 345.6m / 313.1m) |
| TATA: -0.00 (NI 52.6m - CFO 78.2m) / TA 7.23b) |
| Beneish M = -1.89 (Cap -4..+1) = B |
As of July 08, 2026, the stock is trading at USD 20.85 with a total of 181,367 shares traded. Over the past week, the price has changed by -1.60%, over one month by +4.04%, over three months by -4.24% and over the past year by +13.87%.
Current recommended Stop Loss: 20.00 (which is 4.1% or 1.7 ATR below the current price).
NB Bancorp, Common Stock has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy NBBK.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 23 | 10.3% |
P/E Trailing = 15.4307
P/S = 4.1049
P/B = 1.1248
Revenue TTM = 345.6m USD
EBIT TTM = 73.9m USD
EBITDA TTM = 79.8m USD
Long Term Debt = 189.7m USD (from longTermDebt, last quarter)
Short Term Debt = 169.0m USD (from shortLongTermDebt, last fiscal year)
Debt = 189.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -415.3m USD (calculated: Debt 189.7m - CCE 605.0m)
Enterprise Value = 511.6m USD (926.9m + Debt 189.7m - CCE 605.0m)
Interest Coverage Ratio = 0.51 (Ebit TTM 73.9m / Interest Expense TTM 145.8m)
EV/FCF = 7.02x (Enterprise Value 511.6m / FCF TTM 72.8m)
FCF Yield = 14.24% (FCF TTM 72.8m / Enterprise Value 511.6m)
FCF Margin = 21.07% (FCF TTM 72.8m / Revenue TTM 345.6m)
Net Margin = 15.23% (Net Income TTM 52.6m / Revenue TTM 345.6m)
Gross Margin = 54.98% ((Revenue TTM 345.6m - Cost of Revenue TTM 155.6m) / Revenue TTM)
Gross Margin QoQ = 56.80% (prev 46.58%)
Tobins Q-Ratio = 0.07 (Enterprise Value 511.6m / Total Assets 7.23b)
Interest Expense / Debt = 76.85% (Interest Expense 145.8m / Debt 189.7m)
Taxrate = 28.79% (21.3m / 73.9m)
NOPAT = 52.6m (EBIT 73.9m * (1 - 28.79%))
Current Ratio = 1.12 (Total Current Assets 6.84b / Total Current Liabilities 6.10b)
Debt / Equity = 0.23 (Debt 189.7m / totalStockholderEquity, last quarter 842.8m)
Debt / EBITDA = -5.20 (Net Debt -415.3m / EBITDA 79.8m)
Debt / FCF = -5.70 (Net Debt -415.3m / FCF TTM 72.8m)
Total Stockholder Equity = 794.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.84% (Net Income 52.6m / Total Assets 7.23b)
RoE = 6.63% (Net Income TTM 52.6m / Total Stockholder Equity 794.0m)
RoCE = 7.51% (EBIT 73.9m / Capital Employed (Equity 794.0m + L.T.Debt 189.7m))
RoIC = 4.75% (NOPAT 52.6m / Invested Capital 1.11b)
WACC = 7.02% (E(926.9m)/V(1.12b) * Re(8.46%) + (debt cost/tax rate unavailable))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -22.47 | Cagr: -1.35%
[DCF] Terminal Value 77.97% ; FCFF base≈68.5m ; Y1≈78.5m ; Y5≈115.5m
[DCF] Fair Price = 49.11 (EV 1.74b - Net Debt -415.3m = Equity 2.15b / Shares 43.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -1
Revenue Correlation: 93.49 | Revenue CAGR: 22.39% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.47 | Chg30d=+0.00% | Revisions=-25% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.53 | Chg30d=+0.00% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.96 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+14.6% | GrowthRev=+36.8%
EPS next Year (2027-12-31): EPS=2.48 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+26.3% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: -38% (up=1, down=4)